Individualizing Therapy for Non–Small-Cell Lung Cancer: A Paradigm Shift from Empiric to Integrated Decision-Making-Reference-Cited by-同舟云学术

Individualizing Therapy for Non–Small-Cell Lung Cancer: A Paradigm Shift from Empiric to Integrated Decision-Making

Published:2009-05 Issue:3 Volume:10 Page:148-150
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Gandara David R.,Lara Primo N.,Mack Philip,Scagliotti Giorgio

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference20 articles.

1. Phase III, randomized, open-label, first-line study of gefitinib (C) vs carboplatin/paclitaxel (C/P) in clinically selected patients (pts) with advanced non-small-cell lung cancer (NSCLC) (IPASS);Mok;Ann Oncol,2008

2. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer;Sandler;N Engl J Med,2006

3. Outcomes for elderly, advancedstage non–small-cell lung cancer patients treated with bevacizumab in combination with carboplatin and paclitaxel: analysis of Eastern Cooperative Oncology Group Trial 4599;Ramalingam;J Clin Oncol,2008

4. Erlotinib in previously treated non-small-cell lung cancer;Shepherd;N Engl J Med,2005

5. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer;Scagliotti;J Clin Oncol,2008

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utility of Select Gene Mutation Detection in Tumors by the Idylla Rapid Multiplex PCR Platform in Comparison to Next-Generation Sequencing;Genes;2022-04-29

2. Not enough can be enough: feasibility of the Idylla EGFR mutation test when reuse of stained tissue slides is the only option available;Journal of Clinical Pathology;2021-08-16

3. Idylla assay and next generation sequencing: an integrated EGFR mutational testing algorithm;Journal of Clinical Pathology;2018-05-24

4. Systemic Treatment Patterns With Advanced or Recurrent Non–small Cell Lung Cancer in Japan: A Retrospective Hospital Administrative Database Study;Clinical Therapeutics;2017-06

5. Oncogenic roles and drug target of CXCR4/CXCL12 axis in lung cancer and cancer stem cell;Tumor Biology;2016-04-14